Product Information
MAPAP 500 MG CAPSULE is a generic product labeled by Major Pharmaceuticals, priced at $0.0362 per EA under NDC 00904198760. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
500 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904198760
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACETAMINOPHENApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
12/22/1997
Price Statistics
The NADAC for MAPAP 500 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 6.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0362 per EA |
|---|---|
| All-time high | $0.0691 (Jul 12, 2017) |
| All-time low | $0.0278 (Aug 22, 2018) |
| 52-week high | $0.0362 |
| 52-week low | $0.0349 |
| Median price | $0.0362 |
| Average price | $0.0396 |
| Largest weekly change | +56.6% (Jun 21, 2017) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 28% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MAPAP 500 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MAPAP 500 MG CAPSULE, manufactured by Major Pharmaceuticals, is $0.0362 per EA (NDC 00904198760), effective Jun 24, 2026.
How has the price of MAPAP 500 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MAPAP 500 MG CAPSULE has risen 6.7%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MAPAP 500 MG CAPSULE?
Since Nov 28, 2013, the NADAC for MAPAP 500 MG CAPSULE has ranged from a low of $0.0278 (Aug 22, 2018) to a high of $0.0691 (Jul 12, 2017), with a median of $0.0362 per EA.
Are there cheaper alternatives to MAPAP 500 MG CAPSULE?
Yes. 9 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, PAIN RELIEF 500 MG TABLET, is $0.0260 per EA — about 28% below MAPAP 500 MG CAPSULE.
Who manufactures MAPAP 500 MG CAPSULE?
MAPAP 500 MG CAPSULE (NDC 00904198760) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification